Cupric Sulfate; Manganese Sulfate; Selenious Acid; Zinc Sulfate Patent Expiration

1. Multrys patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11975022 AM REGENT NA
Jul, 2041

(16 years from now)

US11786548 AM REGENT Trace element compositions, methods of making and use
Jul, 2041

(16 years from now)




Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) Apr 30, 2024

NCE-1 date: 01 May, 2023

Market Authorisation Date: 30 June, 2021

Treatment: Neonatal and pediatric patients weighing less than 10 kg as a source of zinc, copper, manganese, and selenium for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or ...

Dosage: SOLUTION

More Information on Dosage

MULTRYS family patents

Family Patents

2. Tralement patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11975022 AM REGENT NA
Jul, 2041

(16 years from now)

US11786548 AM REGENT Trace element compositions, methods of making and use
Jul, 2041

(16 years from now)




Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) Apr 30, 2024

NCE-1 date: 01 May, 2023

Market Authorisation Date: 30 June, 2021

Treatment: Adult and pediatric patients weighing at least 10 kg as a source of zinc, copper, manganese, and selenium for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or cont...

Dosage: SOLUTION

More Information on Dosage

TRALEMENT family patents

Family Patents